Xilio Therapeutics, Inc.XLONASDAQ
Loading
Debt-to-equity ratio
3Y CAGR
+1.5%/yr
Annual compound
Percentile
P50
Within normal range
vs 3Y Ago
1x
Modest growth
Streak
1 yr
Consecutive declineElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.20 | -57.4% |
| 2024 | 0.46 | +48.7% |
| 2023 | 0.31 | +64.8% |
| 2022 | 0.19 | +68.8% |
| 2021 | 0.11 | +102.7% |
| 2020 | -4.14 | -956.0% |
| 2019 | 0.48 | - |